» Articles » PMID: 28589752

A Framework for Prospectively Defining Progression Rules for Internal Pilot Studies Monitoring Recruitment

Overview
Publisher Sage Publications
Specialties Public Health
Science
Date 2017 Jun 8
PMID 28589752
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Just over half of publicly funded trials recruit their target sample size within the planned study duration. When recruitment targets are missed, the funder of a trial is faced with the decision of either committing further resources to the study or risk that a worthwhile treatment effect may be missed by an underpowered final analysis. To avoid this challenging situation, when there is insufficient prior evidence to support predicted recruitment rates, funders now require feasibility assessments to be performed in the early stages of trials. Progression criteria are usually specified and agreed with the funder ahead of time. To date, however, the progression rules used are typically ad hoc. In addition, rules routinely permit adaptations to recruitment strategies but do not stipulate criteria for evaluating their effectiveness. In this paper, we develop a framework for planning and designing internal pilot studies which permit a trial to be stopped early if recruitment is disappointing or to continue to full recruitment if enrolment during the feasibility phase is adequate. This framework enables a progression rule to be pre-specified and agreed upon prior to starting a trial. The novel two-stage designs stipulate that if neither of these situations arises, adaptations to recruitment should be made and subsequently evaluated to establish whether they have been successful. We derive optimal progression rules for internal pilot studies which minimise the expected trial overrun and maintain a high probability of completing the study when the recruitment rate is adequate. The advantages of this procedure are illustrated using a real trial example.

Citing Articles

A Bayesian adaptive feasibility design for rare diseases.

Churipuy M, Golchi S, Hudson M, Hoa S Contemp Clin Trials Commun. 2024; 42:101392.

PMID: 39618478 PMC: 11605459. DOI: 10.1016/j.conctc.2024.101392.


Three-outcome designs for external pilot trials with progression criteria.

Wilson D, Hudson E, Brown S BMC Med Res Methodol. 2024; 24(1):226.

PMID: 39358754 PMC: 11446087. DOI: 10.1186/s12874-024-02351-x.


The Hand and Wrist: AntImicrobials and Infection (HAWAII) trial.

Wormald J, Rodrigues J, Bheekharry R, Riley N, Tucker S, Furniss D Br J Surg. 2023; 110(12):1774-1784.

PMID: 37758504 PMC: 10638545. DOI: 10.1093/bjs/znad298.


Applying mixed methods to pilot feasibility studies to inform intervention trials.

Aschbrenner K, Kruse G, Gallo J, Plano Clark V Pilot Feasibility Stud. 2022; 8(1):217.

PMID: 36163045 PMC: 9511762. DOI: 10.1186/s40814-022-01178-x.


Youth Culturally adapted Manual Assisted Problem Solving Training (YCMAP) in Pakistani adolescent with a history of self-harm: protocol for multicentre clinical and cost-effectiveness randomised controlled trial.

Husain N, Tofique S, Chaudhry I, Kiran T, Taylor P, Williams C BMJ Open. 2022; 12(5):e056301.

PMID: 35568489 PMC: 9109112. DOI: 10.1136/bmjopen-2021-056301.